Sign in
4

Changes in Ownership

Immunovant, Inc. Filed Acc 0001764013-24-000165

Chief Executive Officer sold 4,460 shares at $29.56 ($131,838)

From the SEC's structured data for this filing

Trades in this filing

Salzmann Peter · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-10-09 Sale : show line 1 in the form −4,460 $29.56 $131,838 1,003,884 D
Open-market sales · 4,460 sh · avg $29.56 · $131,838
Loading xslF345X05/wk-form4_1728676955.xml…